Global Preterm Birth Prevention and Management Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Preterm Birth Prevention and Management Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Preterm birth is among the prevalent public health concerns all over the world and has become the primary cause of mortality in children aging below 5 years. To curb the alarming situation, governments including, the Food and Drug Administration (FDA), are showing immediacy in approving drugs for preterm birth prevention and management.
Preterm Birth Prevention and Management report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Preterm Birth Prevention and Management market is projected to reach US$ 1760.1 million in 2029, increasing from US$ 1412 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2029. Demand from Hospital and Drugs Stores are the major drivers for the industry.
The preterm birth prevention and management market is driven by the increasing awareness about the adverse effects of preterm birth on neonatal health and the growing emphasis on maternal and child healthcare. Preterm birth, defined as delivery before 37 weeks of pregnancy, poses significant risks to both the baby and the mother. Advances in medical research and technology have led to the development of various interventions and treatments to prevent and manage preterm birth, such as progesterone supplements, cervical cerclage, and improved prenatal care. Additionally, rising healthcare expenditure and government initiatives aimed at reducing preterm birth rates are contributing to the market's growth. However, challenges include the complex and multifactorial nature of preterm birth, making it difficult to predict and prevent in all cases. The effectiveness of interventions can vary depending on individual patient factors, leading to a need for personalized treatment approaches. Furthermore, access to quality healthcare and specialized facilities can be a challenge in some regions, impacting the implementation of effective preterm birth prevention and management strategies. As healthcare systems continue to evolve and research in this field progresses, the preterm birth prevention and management market is expected to witness advancements that improve maternal and neonatal outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Preterm Birth Prevention and Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
AMAG Pharmaceuticals
Ferring Pharmaceutical
Teva
Allergan
AbbVie
Aurobindo Pharma
Bayer
Viatris
Pfizer
Merck & Co
Novartis
Sanofi
Segment by Type
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antihypertensive Therapy
Magnesium Sulfate Therapy
Other
Hospital
Drugs Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Preterm Birth Prevention and Management market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Preterm Birth Prevention and Management introduction, etc. Preterm Birth Prevention and Management Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Preterm Birth Prevention and Management market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Preterm Birth Prevention and Management report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Preterm Birth Prevention and Management market is projected to reach US$ 1760.1 million in 2029, increasing from US$ 1412 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2029. Demand from Hospital and Drugs Stores are the major drivers for the industry.
The preterm birth prevention and management market is driven by the increasing awareness about the adverse effects of preterm birth on neonatal health and the growing emphasis on maternal and child healthcare. Preterm birth, defined as delivery before 37 weeks of pregnancy, poses significant risks to both the baby and the mother. Advances in medical research and technology have led to the development of various interventions and treatments to prevent and manage preterm birth, such as progesterone supplements, cervical cerclage, and improved prenatal care. Additionally, rising healthcare expenditure and government initiatives aimed at reducing preterm birth rates are contributing to the market's growth. However, challenges include the complex and multifactorial nature of preterm birth, making it difficult to predict and prevent in all cases. The effectiveness of interventions can vary depending on individual patient factors, leading to a need for personalized treatment approaches. Furthermore, access to quality healthcare and specialized facilities can be a challenge in some regions, impacting the implementation of effective preterm birth prevention and management strategies. As healthcare systems continue to evolve and research in this field progresses, the preterm birth prevention and management market is expected to witness advancements that improve maternal and neonatal outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Preterm Birth Prevention and Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
AMAG Pharmaceuticals
Ferring Pharmaceutical
Teva
Allergan
AbbVie
Aurobindo Pharma
Bayer
Viatris
Pfizer
Merck & Co
Novartis
Sanofi
Segment by Type
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antihypertensive Therapy
Magnesium Sulfate Therapy
Other
Segment by Application
Hospital
Drugs Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Preterm Birth Prevention and Management market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Preterm Birth Prevention and Management introduction, etc. Preterm Birth Prevention and Management Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Preterm Birth Prevention and Management market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices